Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders.
Saved in:
| Title: | Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders. |
|---|---|
| Authors: | Morant AV; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark., Jagalski V; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark., Vestergaard HT; Regulatory Strategy, H. Lundbeck A/S, Copenhagen, Denmark. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2019 Oct 17; Vol. 6, pp. 223. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31681780 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Morant+AV%22">Morant AV</searchLink>; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Jagalski+V%22">Jagalski V</searchLink>; Regulatory Science & Advocacy, H. Lundbeck A/S, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Vestergaard+HT%22">Vestergaard HT</searchLink>; Regulatory Strategy, H. Lundbeck A/S, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2019 Oct 17; Vol. 6, pp. 223. <i>Date of Electronic Publication: </i>2019 Oct 17 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31681780 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmed.2019.00223 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 223 Titles: – TitleFull: Labeling of Disease-Modifying Therapies for Neurodegenerative Disorders. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Morant AV – PersonEntity: Name: NameFull: Jagalski V – PersonEntity: Name: NameFull: Vestergaard HT IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 10 Text: 2019 Oct 17 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 2296-858X Numbering: – Type: volume Value: 6 Titles: – TitleFull: Frontiers in medicine Type: main |
| ResultId | 1 |